ChemoTech is a Swedish public limited liability company. The Company was established in Sweden. The present Company's date of registration with the Swedish Companies Registration Office is 25 February 2015, and the Company has been in operation since then. The Company complies with the regulations of the Swedish Companies Act (2005:551) and other applicable statutory regulations. The Company is domiciled in Malmö, Sweden.
The basis for the Company's activities is its Articles of Association. In accordance with Article 3 of the Articles of Association, the Company conducts development, production and marketing of medicotechnical equipment, and related activities. The Company's Annual General Meeting adopts the Articles of Association and annually appoints the Board of Directors. The Board of Directors is responsible for the organisation and management of the Company, and the appointment or dismissal of the CEO. The Board of Directors annually lays down written procedures for its work, combined with CEO instructions for the division of work between the Board of Directors and the CEO. Matters concerning remuneration or auditing are decided directly by the Company's Board of Directors. All members of the Board of Directors are elected for a term up to the next Annual General Meeting. Each member of the Board of Directors is entitled to resign at any time.
Board of Directors
Lars Peter Harbing
Born 1958. Chairman since 2015.
Education and experience: Electrical Engineer and Market Economist. Has 20 years' experience from leading international positions in Getinge AB and Johnson & Johnson, including President, Getinge USA, WW President ASP and President, Ethicon Endosurgery EMEA.
Current assignments: Member of the Board of Directors of Carmona Holding AB, Carponovum AB, Consector AB, Scandinavia RealHeart AB, AB Halmstad Golf Club. CEO, Harbing Management AB.
Previous assignments (last five years): -
Born 1944. Member of the Board of Directors since 2013.
Education and experience: Licensed physician. Formerly head of the surgical department at Huddinge Hospital.
Current assignments: Chairman of Scandinavian Real Heart AB, Hellers Medical AB, Laprotech AB. Member of the Board of Directors of Scandinavian Care AB, Scandinavian Care Investment AB, Scandinavian Care Consulting AB, Scandinavian Care Holding AB, Fricks Property & Equity AB, Scandinavian Medical Development Mind AB, MDM Medical Development Mind AB.
Previous assignments (last five years): Chairman, Transsafe AB.
Born 1945. Member of the Board of Directors since 2015.
Education and experience: MSc (business and economics), Lund, 1970. Formerly Chairman and CEO of Arjo AB, vice CEO, Tarkett, and head of department, Malmros International.
Current assignments: -
Previous assignments (last five years): Chairman, Fagerhult. Vice-Chairman, Sweco. Member of the Board of Directors of Securitas, Getinge, Lifco, Nordea-region SOUTH.
Born 1975. Member of the Board of Directors since 2015.
Education and experience: MSc, Business and Economics (1995-2000). Has extensive banking and financial experience from e.g. Nordea.
Current assignments: Chief Dealer, Head of Credit Trading Sweden, Nordea Markets (2007-today).
Previous assignments: Institutional Sales, Fixed Income, Nordea Markets (2004-2007). Credit analyst and Debt Capital Market, HSH Nordbank (2002-2004). Manpower konsult - Skandia fonder, SEB Merchant Banking, Handelsbanken Asset Management (2000-2002).
IngaLill Forslund Larsson
Born 1954. Member of the Board of Directors since 2018.
Education and experience: University degree in Economics and Marketing. Leg. Midwife and Nurse. Extensive experience from marketing & sales and business development. Business responsibility as Head of Urology Global Marketing at Ferring Pharmaceuticals and commercial roles for AstraZeneca.
Current assignments: Board member of LIDDS Pharmaceuticals, Truly Labs AB. CEO, co-owner and board member of private real estate companies (Ellet Assets AB; Fastighets AB Olshög, Nible Invest AB, Nöbbe Gård AB, Nöbbe Gård Projekt AB)
Previous assignments (last five years): Sr consultant Lisberg Executive Search, Chairman of the Board XImmune AB, Boardmember LU Bioscience AB.
Born 1974. Member of the Board of Directors and CEO since 2015.
Education and experience: BA, Marketing, Management, Lund University. 20 years' experience as market manager, sales manager and Board member of life science companies. Has among other things held positions in ArjoHuntleigh, Getinge, Navigator Communications, Insulution AB, OnMeD and SYSMEX.
Current assignments: Chairman of Scandinavian MediTech (Indian subsidiary), Fricks Property & Equity Invest AB.
Previous assignments (last five years): Member of the Board of Directors of Insulution AB 2009-2011, Onmed International 2012-March 2013, Onmed India Private Limited 2011-June 2014. Member of the Advisory Board for Billion Minds Foundation 2009-2014.
CEO, founder and member of the Board of Directors. See under "Board of Directors".
Born 1977. CFO since 2016.
Education and experience: 2001 MSc, Accounting and Finance, Lund University. 15 years' experience primarily as CFO/Finance Manager and Controller of international industrial and service companies.
Current assignments: -
Previous assignments (last five years): CFO & Supply Chain Manager CeDe Group AB. Manager CeDe Group AB. Accounting Manager, Consafe Logistics AB.
The Company's Certified Adviser is Västra Hamnen Corporate Finance. The task of the Certified Adviser is to serve as adviser to the Company in matters relating to the IPO and information.
Västra Hamnen Corporate Finance AB
SE-211 19 Malmö
(+46) (0)40-200 250
(+46) (0)40-200 250
Auditor responsible Karin Löwhagen
Deputy auditor Katarina Holm